DLST / DLTS antibody
Principal name
DLST / DLTS antibody
Alternative names for DLST / DLTS antibody
E2K, OGDC-E2, Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex
Ncbi ID
NP_001924.2, NM_001933, NP_001924, NP_084501.1, NM_030225, NM_001006981
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), Immunocytochemistry/Immunofluorescence (ICC/IF), Immunoprecipitation (IP), Paraffin Sections (P)
Background of DLST / DLTS antibody
- Kit Component:
- - KN304623G1, Dlst gRNA vector 1 in pCas-Guide vector
- KN304623G2, Dlst gRNA vector 2 in pCas-Guide vector
- KN304623D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
DLST polyclonal antibody (A01), Lot # 060803QCS1. Western Blot analysis of DLST expression in U-2 OS.
DLST polyclonal antibody (A01), Lot # 051123JC01 Western Blot analysis of DLST expression in HeLa ( Cat # L013V1 ).
Immunofluorescence of purified MaxPab antibody to DLST on HeLa cell. [antibody concentration 10 ug/ml]
DLST MaxPab polyclonal antibody. Western Blot analysis of DLST expression in human liver.
Western Blot analysis of DLST expression in transfected 293T cell line (H00001743-T01) by DLST MaxPab polyclonal antibody.Lane 1: DLST transfected lysate(49.83 KDa).Lane 2: Non-transfected lysate.
DLST MaxPab polyclonal antibody. Western Blot analysis of DLST expression in HepG2.
DLST MaxPab rabbit polyclonal antibody. Western Blot analysis of DLST expression in human kidney.
Western Blot analysis of DLST expression in transfected 293T cell line (H00001743-T02) by DLST MaxPab polyclonal antibody.Lane 1: DLST transfected lysate(48.80 KDa).Lane 2: Non-transfected lysate.
DLST MaxPab rabbit polyclonal antibody. Western Blot analysis of DLST expression in HepG2.
Human Placenta; WB Suggested Anti-DLST Antibody. . Titration: 1.0 ug/ml. . Positive Control: Placenta; DLST antibody - C-terminal region (ARP61476_P050) in Human Placenta cells using Western Blot
Sample (30 ug of whole cell lysate). A: A431 . 10% SDS PAGE. TA307907 diluted at 1:1000.
Immunohistochemical analysis of paraffin-embedded Cal27 xenograft, using DLST(TA307907) antibody at 1:500 dilution.
Immunohistochemical analysis of paraffin-embedded RT2 xenograft, using DLST(TA307907) antibody at 1:500 dilution.
Immunofluorescence analysis of methanol-fixed A431, using DLST(TA307907) antibody at 1:500 dilution.
- Quick-Filters:
- Highly Validated (1)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA307907 | DLST / DLTS antibody |
||||||
| Rabbit Polyclonal antibody to DLST (dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex)) | |||||||
 |
Rabbit | IgG | Aff - Purified | Hu | ICC/IF, P, WB |
0.1 ml /
€416.00
|
|
| OriGene Technologies, Inc. | |||||||
 +3 additional images |
Highly validated antibody! |
||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP301220 | DLST / DLTS |
||||
| Recombinant protein of human dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) (DLST) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€438.00
|
|
| OriGene Technologies, Inc. | |||||
|
|||||
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC201220L2V | Lenti ORF particles, DLST (mGFP-tagged) - Human dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) (DLST), transcript variant 1, 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€1,082.00
|
|
| OriGene Technologies, Inc. | ||
| RC201220L1V | Lenti ORF particles, DLST (Myc-DDK tagged) - Human dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) (DLST), transcript variant 1 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€969.00
|
|
| OriGene Technologies, Inc. | ||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR207251L2V | Lenti ORF particles, Dlst (GFP-tagged) - Mouse dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) (Dlst), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,092.00
|
|
| OriGene Technologies, Inc. | ||
| MR207251L1V | Lenti ORF particles, Dlst (Myc-DDK-tagged) - Mouse dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) (Dlst), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€979.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR214067L2V | Lenti ORF particles, Dlst (GFP-tagged ORF) - Rat dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) (Dlst), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,092.00
|
|
| OriGene Technologies, Inc. | ||
| RR214067L1V | Lenti ORF particles, Dlst (Myc-DDK-tagged ORF) - Rat dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) (Dlst), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€975.00
|
|
| OriGene Technologies, Inc. | ||
